PRKN and Alzheimer disease: A progressive reduction in Parkin expression was observed in both AD patient brains as well as mutant human amyloid precursor protein transgenic mice (hAPP Tg) mouse models, suggesting an impairment in the effective activation of Parkin-mediated mitophagy during disease progression [79].